| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/16/2000 | CN1244529A Novel 8H-thiophene [2,3-b] pyrrolinezine-8-on compound, its preparing method and their medicinal compounds containing them |
| 02/15/2000 | US6025371 Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones |
| 02/15/2000 | CA2119218C Enantioselective synthesis of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno 2,3-b thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/09/2000 | EP0977759A1 Crf antagonistic thiophenopyridines |
| 02/09/2000 | EP0977754A1 Writable and erasable high-density optical storage media |
| 02/09/2000 | EP0977752A1 Herbicidal pyrazoles |
| 02/09/2000 | CN1244201A Heterocyclic metallocenes and polymerization catalysts |
| 02/08/2000 | US6022307 Angiogenesis inhibitor |
| 02/03/2000 | WO2000005234A1 NF-λB INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 02/03/2000 | WO2000004899A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004898A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | CA2337399A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2337349A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/02/2000 | EP0975639A1 Compounds |
| 02/02/2000 | EP0975619A1 INTENSE COLOURING PHOTOCHROMIC 2$i(H)-NAPHTHO 1,2-$i(b)]PYRANS AND HETEROCYCLIC PYRANS |
| 02/02/2000 | EP0975602A1 Imidazole and imidazoline derivatives and uses thereof |
| 02/02/2000 | EP0975600A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/01/2000 | US6020487 Intermediates and process for preparing olanzapine |
| 02/01/2000 | US6020343 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
| 02/01/2000 | US6020342 Fused imidazo[1,2-A]pyridines |
| 01/27/2000 | WO2000004027A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | WO2000004023A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | CA2337771A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | CA2336950A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/26/2000 | EP0973778A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/26/2000 | EP0973777A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 01/26/2000 | EP0973772A1 Compounds |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | CN1242773A Ticyclic carbapenem compound |
| 01/25/2000 | US6018054 Intermediate compounds for preparing novel quinolone and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, use as antibacterial agents and as feed additives |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/20/2000 | WO2000002861A1 A3 adenosine receptor antagonists |
| 01/20/2000 | WO2000002555A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | CA2336932A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 01/19/2000 | EP0971931A1 Method for debenzylation of dibenzyl biotin |
| 01/19/2000 | EP0971914A2 NEUTRAL COLOURING PHOTOCHROMIC 2$i(H)-NAPHTHO 1,2-$i(b)]PYRANS AND HETEROCYCLIC PYRANS |
| 01/19/2000 | EP0971748A2 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin |
| 01/18/2000 | US6015817 Inhibitors of farnesyl-protein transferase |
| 01/18/2000 | US6015810 Aqueous ophthalmic solution containing apafant as active ingredient |
| 01/18/2000 | CA2000985C 1,4-diazepine derivative and its pharmaceutical use |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/12/2000 | EP0970956A1 Pyrazole derivatives |
| 01/12/2000 | EP0970086A1 Spiro compounds and the use thereof |
| 01/12/2000 | EP0559891B1 Thienodiazepine compound and its use |
| 01/11/2000 | US6013807 Amidation to produce compound having low toxicity and antitumor activity |
| 01/11/2000 | US6013656 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors |
| 01/11/2000 | US6013655 Hypotensive agents; respiratory system diisorders |
| 01/11/2000 | US6013652 Spiro-substituted azacycles as neurokinin antagonists |
| 01/06/2000 | WO2000000493A1 Thienopyridine compounds, their production and use |
| 01/06/2000 | CA2331399A1 Thienopyridine compounds, their production and use |
| 01/05/2000 | CN1240450A Thienopyrimidine with phosphodiesterase V inhibiting effect |
| 01/05/2000 | CN1240449A Substituted phenylketoenols and their use as pesticides and herbicides |
| 01/05/2000 | CN1240440A Substituted benzothiopyranes salts and their use as herbicides |
| 01/05/2000 | CN1240212A Process for reducing prochiral ketone to produce optically active alcohol of high optical purity |
| 01/04/2000 | US6011029 Benzodiazepine compounds |
| 12/29/1999 | WO1999067228A1 Fluorophenyl resin compounds |
| 12/29/1999 | WO1999067202A1 Process for preparation of pyrimidinone derivatives |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066925A1 Protease inhibitors |
| 12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
| 12/29/1999 | EP0966454A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 12/29/1999 | CA2335876A1 Protease inhibitors |
| 12/29/1999 | CA2335760A1 Fluorophenyl resin compounds |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis |
| 12/23/1999 | WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | WO1999065916A1 Thienodipyridine derivatives, production and use thereof |
| 12/23/1999 | WO1999065915A1 Polymorphic clopidogrel hydrogenesulphate form |
| 12/23/1999 | WO1999065910A1 Fused azepinone cyclin dependent kinase inhibitors |
| 12/23/1999 | CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | CA2335106A1 Thienodipyridine derivatives, production and use thereof |
| 12/22/1999 | EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| 12/21/1999 | US6005083 Substituted metal chelating compounds for imaging and therapy |
| 12/21/1999 | US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 12/21/1999 | US6004964 Administering amide or sulfonamide derivative; analgesics |
| 12/16/1999 | WO1999064425A1 Substituted thienocycloalkylpyrazoles: dopamine receptor subtype specific ligands |
| 12/16/1999 | WO1999064420A1 β-CARBOLINE COMPOUNDS |
| 12/16/1999 | WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064054A1 Multibinding inhibitors of topoisomerase |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064051A1 Novel antibacterial compounds |
| 12/16/1999 | WO1999064049A1 Novel antibacterial agents |